CTOs on the Move

Impel NeuroPharma

www.impelneuropharma.com

 
Impel NeuroPharma is a Seattle-based company developing intranasal drug treatments for central nervous system (CNS) disorders. Impel has developed a novel drug delivery platform, the POD technology, that administers drug to the deep nasal cavity to improve the brain distribution of many drugs. Impel`s proprietary (POD) device technology enables entirely new categories of drugs, including biologics, to be delivered to the central nervous system using a cost-effective, disposable, non-invasive intranasal drug delivery device.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Impel NeuroPharma raised $36M on 12/02/2016
Impel NeuroPharma raised $67.5M on 12/06/2018

Similar Companies

Teleflex

Teleflex is a global provider of medical devices used in critical care and surgery. We serve healthcare providers with specialty devices for vascular access, general and regional anesthesia, urology, respiratory care, cardiac care and surgery.

OrbusNeich

OrbusNeich is a Fort Lauderdale, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Philadelphia County Medical Society

Philadelphia County Medical Society is a Harrisburg, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cytori Therapeutics

Cytori Therapeutics is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MicroMed Cardiovascular Inc.

MicroMed Cardiovascular Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.